Caricamento...
Use of parecoxib by continuous subcutaneous infusion for cancer pain in a hospice population
OBJECTIVES: To characterise the use of the parenteral non-steroidal anti-inflammatory drug parecoxib when given by continuous subcutaneous infusion (CSCI) in a hospice population. Clinical experience suggests parecoxib CSCI may be of benefit in this population, but empirical evidence in relation to...
Salvato in:
| Pubblicato in: | BMJ Support Palliat Care |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMJ Publishing Group
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5867430/ https://ncbi.nlm.nih.gov/pubmed/28864447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjspcare-2017-001348 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|